Aytu BioPharma, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Aytu BioPharma, Inc. now
Current reporting with the operating signal separated from the noise.
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
Investors are testing whether Aytu BioPharma, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2023 Earnings Call Transcript
Investors are testing whether Aytu BioPharma, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript
Investors are testing whether Aytu BioPharma, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest AYTU filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Aytu BioPharma, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →